Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases.

Ankrah AO, Glaudemans AWJM, Klein HC, Dierckx RAJO, Sathekge M.

Nucl Med Mol Imaging. 2017 Jun;51(2):127-139. doi: 10.1007/s13139-016-0422-0. Epub 2016 May 25. Review.

PMID:
28559937
2.

Severe Thrombocytopenia and Acute Cytomegalovirus Colitis during Primary Human Immunodeficiency Virus Infection.

Furuhata M, Yanagisawa N, Nishiki S, Sasaki S, Suganuma A, Imamura A, Ajisawa A.

Intern Med. 2016;55(24):3671-3674. Epub 2016 Dec 15.

3.

Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin.

Gelpi M, Hartling HJ, Thorsteinsson K, Gerstoft J, Ullum H, Nielsen SD.

BMC Infect Dis. 2016 Oct 21;16(1):591.

4.

Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.

Lord E, Stockdale AJ, Malek R, Rae C, Sperle I, Raben D, Freedman A, Churchill D, Lundgren J, Sullivan AK; British Association of Sexual Health HIV (BASHH)/British HIV Association (BHIVA) guideline review group for the Optimising Testing and Linkage to Care for HIV across Europe (OptTEST) project by HIV in Europeb.

HIV Med. 2017 Apr;18(4):300-304. doi: 10.1111/hiv.12430. Epub 2016 Aug 18.

5.

Impact of Depression and Inflammation on the Progression of HIV Disease.

Rivera-Rivera Y, Vázquez-Santiago FJ, Albino E, Sánchez MD, Rivera-Amill V.

J Clin Cell Immunol. 2016 Jun;7(3). pii: 423. Epub 2016 Jun 3.

6.

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Robb ML, Eller LA, Kibuuka H, Rono K, Maganga L, Nitayaphan S, Kroon E, Sawe FK, Sinei S, Sriplienchan S, Jagodzinski LL, Malia J, Manak M, de Souza MS, Tovanabutra S, Sanders-Buell E, Rolland M, Dorsey-Spitz J, Eller MA, Milazzo M, Li Q, Lewandowski A, Wu H, Swann E, O'Connell RJ, Peel S, Dawson P, Kim JH, Michael NL; RV 217 Study Team.

N Engl J Med. 2016 Jun 2;374(22):2120-30. doi: 10.1056/NEJMoa1508952. Epub 2016 May 18.

7.

Lymphoid Tissue Mesenchymal Stromal Cells in Development and Tissue Remodeling.

Genovese L, Brendolan A.

Stem Cells Int. 2016;2016:8419104. doi: 10.1155/2016/8419104. Epub 2016 Apr 13. Review.

8.

Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.

Bissel SJ, Kofler J, Nyaundi J, Murphey-Corb M, Wisniewski SR, Wiley CA.

J Neuroimmune Pharmacol. 2016 Jun;11(2):332-47. doi: 10.1007/s11481-016-9666-9. Epub 2016 Apr 8.

9.

Neurobehavioral Disturbances During Acute and Early HIV Infection.

Kamat R, Doyle KL, Iudicello JE, Morgan EE, Morris S, Smith DM, Little SJ, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Cogn Behav Neurol. 2016 Mar;29(1):1-10. doi: 10.1097/WNN.0000000000000084.

10.

Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.

Krebs SJ, Slike BM, Sithinamsuwan P, Allen IE, Chalermchai T, Tipsuk S, Phanuphak N, Jagodzinski L, Kim JH, Ananworanich J, Marovich MA, Valcour VG; SEARCH 011 study team.

AIDS. 2016 Jun 19;30(10):1533-42. doi: 10.1097/QAD.0000000000001096.

11.

Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM.

Stekler JD, Ure G, O'Neal JD, Lane A, Swanson F, Maenza J, Stevens C, Coombs RW, Dragavon J, Swenson PD, Golden MR.

J Clin Virol. 2016 Mar;76:8-13. doi: 10.1016/j.jcv.2015.12.011. Epub 2016 Jan 2.

12.

Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis.

Cao B, Kong X, Kettering C, Yu P, Ragin A.

Neuroimage Clin. 2015 Aug 1;9:75-82. doi: 10.1016/j.nicl.2015.07.012. eCollection 2015.

13.

Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

Sunshine JE, Larsen BB, Maust B, Casey E, Deng W, Chen L, Westfall DH, Kim M, Zhao H, Ghorai S, Lanxon-Cookson E, Rolland M, Collier AC, Maenza J, Mullins JI, Frahm N.

J Virol. 2015 Oct;89(20):10303-18. doi: 10.1128/JVI.01876-15. Epub 2015 Jul 29.

14.

Accounting for dropout reason in longitudinal studies with nonignorable dropout.

Moore CM, MaWhinney S, Forster JE, Carlson NE, Allshouse A, Wang X, Routy JP, Conway B, Connick E.

Stat Methods Med Res. 2015 Jun 15. pii: 0962280215590432. [Epub ahead of print]

15.

Knowledge and awareness of acute human immunodeficiency virus infection among mobile app-using men who have sex with men: a missed public health opportunity.

Siegler AJ, Sanchez T, Sineath RC, Grey J, Kahle E, Sullivan PS.

Open Forum Infect Dis. 2015 Feb 23;2(1):ofv016. doi: 10.1093/ofid/ofv016. eCollection 2015 Jan.

16.

Brief Report: Health-Seeking Behavior and Symptoms Associated With Early HIV Infection: Results From a Population-Based Cohort in Southern Malawi.

Yeatman SE, Hoffman RM, Chilungo A, Lungu SR, Namadingo HC, Chimwaza AF, Trinitapoli JA.

J Acquir Immune Defic Syndr. 2015 May 1;69(1):126-30. doi: 10.1097/QAI.0000000000000536.

17.

Chemokine co-receptor usage in HIV-1-infected treatment-naïve voluntary counselling and testing clients in Southern Taiwan.

Tsai HC, Chou PY, Wann SR, Lee SS, Chen YS.

BMJ Open. 2015 Apr 29;5(4):e007334. doi: 10.1136/bmjopen-2014-007334.

18.

Testing initiatives increase rates of HIV diagnosis in primary care and community settings: an observational single-centre cohort study.

Mahendran P, Soni S, Goubet S, Saunsbury E, Roberts J, Fisher M.

PLoS One. 2015 Apr 17;10(4):e0124394. doi: 10.1371/journal.pone.0124394. eCollection 2015.

19.

Evaluation of a HIV voluntary opt-out screening program in a Singapore hospital.

Tan XQ, Goh WP, Venkatachalam I, Goh D, Sridhar R, Chan HC, Archuleta S.

PLoS One. 2015 Jan 22;10(1):e0116987. doi: 10.1371/journal.pone.0116987. eCollection 2015.

20.

Supplemental Content

Support Center